Pashtoon Kasi MD, MS (@pashtoonkasi) 's Twitter Profile
Pashtoon Kasi MD, MS

@pashtoonkasi

Oncologist | Researcher | ColorectalCancer #CRCSM👨🏼‍🎓@MayoClinic @PittTweet Alum; 🧬#ctDNA #LiquidBiopsies💡#PrecisionOncology ViewsMy Own. COI @ASCO

ID: 589105446

linkhttps://coi.asco.org/share/PT3-AL5H/Pashtoon%20Kasi calendar_today24-05-2012 10:45:12

15,15K Tweet

18,18K Followers

11,11K Following

Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Retrospective study from Natera and Gregory Botta in The Oncologist Association of personalized and tumor-informed ctDNA with patient survival outcomes in #PancreaticCancer academic.oup.com/oncolo/advance… "In multivariate analysis, ctDNA detection at surveillance was found to be

Retrospective study from <a href="/NateraGenetics/">Natera</a> and <a href="/gregorybotta/">Gregory Botta</a> in <a href="/OncJournal/">The Oncologist</a> 
Association of personalized and tumor-informed ctDNA with patient survival outcomes in #PancreaticCancer
academic.oup.com/oncolo/advance…
"In multivariate analysis, ctDNA detection at surveillance was found to be
WCM Englander Institute for Precision Medicine (@wcmenglanderipm) 's Twitter Profile Photo

Congratulations to our WCM Englander Institute for Precision Medicine colleague Dr. Pinkal Desai (Pinkal Desai) on her new ACS Journal Cancer paper "Association of #clonalhematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality." #mCAs #CHIP #WGS acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Congratulations to our <a href="/WCMEnglanderIPM/">WCM Englander Institute for Precision Medicine</a> colleague Dr. Pinkal Desai (<a href="/DrPinkalDesai/">Pinkal Desai</a>) on her new <a href="/JournalCancer/">ACS Journal Cancer</a> paper "Association of #clonalhematopoiesis and mosaic chromosomal alterations with solid malignancy incidence and mortality." #mCAs #CHIP #WGS 

acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…
PER (@gotoper) 's Twitter Profile Photo

Enhance your knowledge and network with leading professionals in Hollywood, FL this fall at this year's ISGIO! Don’t miss this opportunity to advance your expertise in GI oncology! Register now: bit.ly/4cOUPMy Tanios Bekaii-Saab, MD Eileen M O’Reilly

Enhance your knowledge and network with leading professionals in Hollywood, FL this fall at this year's ISGIO! Don’t miss this opportunity to advance your expertise in GI oncology! Register now: bit.ly/4cOUPMy <a href="/GIcancerDoc/">Tanios Bekaii-Saab, MD</a> <a href="/EileenMOReilly/">Eileen M O’Reilly</a>
ASCO (@asco) 's Twitter Profile Photo

👏 Join us in congratulating our members who earned the Fellows of ASCO (FASCO) distinction this quarter! We're grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wLvZf

👏 Join us in congratulating our members who earned the Fellows of ASCO (FASCO) distinction this quarter! We're grateful for their extraordinary volunteer service, dedication, and commitment to ASCO. Learn more about FASCO distinction: brnw.ch/21wLvZf
Myriam Chalabi (@myriamchalabi) 's Twitter Profile Photo

Abstract titles for #ESMO24 now online! Full NICHE-3 cohort (59 pts with dMMR colon cancer treated with neoadj nivo/rela) will be presented in proferred paper session + more neoadj IO from Imhotep, and wonderful Jenny Seligmann as discussant. Stay tuned for more exciting💥💥💥news!

Abstract titles for #ESMO24 now online! Full NICHE-3 cohort (59 pts with dMMR colon cancer treated with neoadj nivo/rela) will be presented in proferred paper session + more neoadj IO from Imhotep, and wonderful <a href="/JenSeligmann/">Jenny Seligmann</a> as discussant. Stay tuned for more exciting💥💥💥news!
Anirban Maitra (@aiims1742) 's Twitter Profile Photo

Based on the ECLIPSE trial, U.S. FDA today approved the Guardant SHIELD blood test for #ColorectalCancer. Matthew Herper in STAT statnews.com/2024/07/29/gua… See ECLIPSE data below & why individuals undergoing this assay should clearly understand - this is NOT a test for CRC

Fight Colorectal Cancer (@fightcrc) 's Twitter Profile Photo

The FDA has approved the Shield blood test as a primary screening option for colorectal cancer, providing patients with more choices for screening. Here is our response. 🧵

The FDA has approved the Shield blood test as a primary screening option for colorectal cancer, providing patients with more choices for screening. 
Here is our response. 🧵
Dr. Cathy Eng (@cathyengmd) 's Twitter Profile Photo

Congratulations to my longstanding friend and co-Vail AACR/ASCO workshop alumni 🤩 Smitha Krishnamurthi Cleveland Clinic for being elected by her peers as the new NCI CTEP Clinical Research National Cancer Institute #colon Task Force Co-Chair! Well deserved!!!! 👏👏👏 SWOG Cancer Research Network #CancerResearch #cancer

Congratulations to my longstanding friend and co-Vail AACR/ASCO workshop alumni 🤩 <a href="/smitha42/">Smitha Krishnamurthi</a> <a href="/ClevelandClinic/">Cleveland Clinic</a>  for being elected by her peers as the new <a href="/NCICTEP_ClinRes/">NCI CTEP Clinical Research</a> <a href="/theNCI/">National Cancer Institute</a> #colon Task Force Co-Chair! Well deserved!!!! 👏👏👏 <a href="/SWOG/">SWOG Cancer Research Network</a> #CancerResearch #cancer
Smitha Krishnamurthi (@smitha42) 's Twitter Profile Photo

Thank you so much Dr. Cathy Eng ! My dear friend all these years!🙏🏾🙏🏾🙏🏾 So grateful for the opportunity to work with Jonathan Loree and the NCI CTEP Clinical Research Colon Task Force to advance NCTN concepts!

David Gandara (@drgandara) 's Twitter Profile Photo

#ISLB24 So happy to have Daniel Cheung, 1st author of the recent NEJM paper on liquid biopsy in the screening of colorectal cancer, as keynote speaker at our annual ISLB Congress. If you are working in the liquid biopsy space, participation in ISLB24 is a must do. See you there!

Fatima Qadri MD (@qad_fatima) 's Twitter Profile Photo

I am eager to share that I received my ECFMG certification a few days ago. It’s unreal how years of hard work, countless exams, sleepless nights, my family’s unwavering support (and admittedly lots of tears) has finally culminated into a single piece of paper! 🙌🏽 #Match2025

I am eager to share that I received my ECFMG certification a few days ago. It’s unreal how years of hard work, countless exams, sleepless nights, my family’s unwavering support (and admittedly lots of tears) has finally culminated into a single piece of paper! 🙌🏽
#Match2025
Mark Lewis, MD, FASCO (@marklewismd) 's Twitter Profile Photo

📢Calling all oncology researchers! We’re accepting submissions for JCO Oncology Advances #JCO #OncologyResearch #OpenAccess Share impactful cancer research with a global community and contribute to advancing clinical oncology. Submit your work: ascopubs.org/journal/oa

OncoAlert (@oncoalert) 's Twitter Profile Photo

Dear Colleagues, The OncoAlert 🚨Network Presents OUR Picks of TOP 🔟 GI Abstracts to be Presented at #ESMO24 This List Curated by: #OncoAlertAF Leads Dr Joseph McCollom DO 🇺🇸 Erman Akkus 🇹🇷 Gil Morgan, MD 🇺🇸 1141O - Cabozantinib versus placebo for advanced neuroendocrine tumors

Dear Colleagues, 
The <a href="/OncoAlert/">OncoAlert</a> 🚨Network Presents OUR Picks of  TOP 🔟 GI Abstracts to be Presented at #ESMO24 

This List Curated by: #OncoAlertAF Leads
<a href="/realbowtiedoc/">Dr Joseph McCollom DO</a> 🇺🇸
<a href="/Erman_Akkus/">Erman Akkus</a> 🇹🇷
<a href="/weoncologists/">Gil Morgan, MD</a> 🇺🇸

1141O - Cabozantinib versus placebo for advanced neuroendocrine tumors